Skip to main content
[Preprint]. 2023 Nov 17:2023.11.16.567457. [Version 1] doi: 10.1101/2023.11.16.567457

Table 1:

Patient cohorts for this study

N
Patients 21
Samples
Tumor 18
Stroma 21
Treatments (patients)
Ipi-Nivo 2 (4)
Pembo-Axi 4 (7)
None 15 (28)
Sarcomatoid: IO naïve
No 8 (14)
Yes 7 (14)
Median Survival (months)*
Pre-IO Non-Sarcomatoid 69.5
Pre-IO Sarcomatoid 29.9
Post-IO 15.2